Federal award (PURCHASE ORDER, fiscal year 2024)
Recipient: DEXORGEN INC.
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2025-09-18 to 2026-09-17
Current total value of award: $13200
Description: DEVELOP AND OPTIMIZE ANTAGONISTS ASSAYS IN ACVR1-WT, ACVR1-R206H,ACVR1-T283I AND ACVR1-R206H-T283I CELLS